About Sacred Heart Medical Group
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sacred Heart Medical Group
During the past decade, Sacred Heart Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
1993-04-01
Completed
1,929
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
1998-10-01
Completed
571
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
2001-07-01
2012-09-01
Completed
35,533
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sacred Heart Medical Group"
#1 collaborator was "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sacred Heart Medical Group
According to Clinical.Site data, the most researched conditions in "Sacred Heart Medical Group" are
"Hepatocellular Carcinoma" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Sacred Heart Medical Group" in a lesser frequency.
Clinical Trials Intervention Types at Sacred Heart Medical Group
Most popular intervention types in "Sacred Heart Medical Group" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cabozantinib" (1 trials), "Ipilimumab" (1 trials), "Nivolumab" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sacred Heart Medical Group
The vast majority of trials in "Sacred Heart Medical Group" are
2 trials for "All" genders.
Clinical Trials Status at Sacred Heart Medical Group
Currently, there are NaN active trials in "Sacred Heart Medical Group".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sacred Heart Medical Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sacred Heart Medical Group, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".